跳至主要内容
临床试验/ACTRN12621001025820
ACTRN12621001025820已完成未知

Effects of therapeutic ultrasound on breastmilk composition of mothers who are 1-6 months post partum and exclusively breastfeeding

Curtin University0 个研究点目标入组 26 人开始时间: 2021年8月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
26

研究概览

简要总结

The research question was whether therapeutic ultrasound changed the composition of breastmilk. Inflammatory conditions of the lactating breast (ICLB), e.g. mastitis and engorgement, are a common problem for women after childbirth, which may cause breast pain, firmness or lumps, redness, warmth, flu-like symptoms and fever. Most physiotherapists treat ICLB with education and therapeutic ultrasound (TUS), which may help to reduce inflammation, improve tissue healing and clear blocked ducts. Mothers aged over 18 who were fully breastfeeding with babies aged between 1-6 were included. Any mother who was mixed feeding or giving their babies solids or who had a history and/or current ICLB were excluded. Results of this study showed that there was no adverse change within the concentration of breastmilk protein, lactose and fat after the application of therapeutic ultrasound to the breast.

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • English-speaking mothers aged over 18 whose infants are aged between 1-6 months, who are fully breastfeeding (i.e. not pumping more than twice a day).

排除标准

  • Mothers who are mixed feeding (i.e. with formula or solids) or have a history and/or current inflammatory condition of the lactating breast will be excluded. Women who have a current pregnancy; known or suspected cancer; circulation problems; bleeding disorders; acute infection; disease of the nervous system; heart condition or cardiac pacemaker and any other electronic, metallic or breast implants will be excluded as they will be ineligible to receive therapeutic ultrasound.

研究者

相似试验